Author Correction: BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape
David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsColorectal Cancer Treatments and Studies · Melanoma and MAPK Pathways · Lung Cancer Treatments and Mutations
Correction to: npj Precision Oncology 10.1038/s41698-024-00552-7, published online 16 April 2024
In the Acknowledgements section, the funding source was omitted. The original article has been corrected.